ImageneBio names Yanina Grant-Huerta CFO

Reuters2026/07/23 20:47

By:Reuters

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold. Trade now!

A welcome pack worth 6200 USDT for new users! Sign up now!

ImageneBio named Yanina Grant-Huerta chief financial officer, effective July 20, 2026; she had been chief accounting officer at Atara Biotherapeutics.
Grant-Huerta held finance planning and accounting roles at Atara since April 2020; previously spent 14 years at Amgen in finance planning roles.
CEO Kristin Yarema had served as interim principal financial officer until the appointment.
Chief medical officer Benjamin Porter-Brown will shift to a consulting role on July 24, 2026, advising on clinical development strategy.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. ImageneBio Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001193125-26-314167), on July 23, 2026, and is solely responsible for the information contained therein.

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.

Trade now！

ImageneBio names Yanina Grant-Huerta CFO

You may also like

Crypto prices